BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M, Terai S, Nishikawa H, Hiasa Y, Hidaka H, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K. Evidence-based clinical practice guidelines for Liver Cirrhosis 2020. J Gastroenterol 2021;56:593-619. [PMID: 34231046 DOI: 10.1007/s00535-021-01788-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Obara K. Endoscopic treatment of esophagogastric varices. Dig Endosc 2021. [PMID: 34719803 DOI: 10.1111/den.14166] [Reference Citation Analysis]
2 Eso Y. Questionnaire-based approach to sleep-wake disturbance in patients with chronic liver disease. Hepatol Res 2022;52:327-8. [PMID: 35366385 DOI: 10.1111/hepr.13760] [Reference Citation Analysis]
3 Liu B, Li G, Li S. Progress in Endoscopic and Interventional Treatment of Esophagogastric Variceal Bleeding. Disease Markers 2022;2022:1-6. [DOI: 10.1155/2022/2940578] [Reference Citation Analysis]
4 Chen XY, Wang C, Huang YZ, Zhang LL. Nonalcoholic fatty liver disease shows significant sex dimorphism. World J Clin Cases 2022; 10(5): 1457-1472 [DOI: 10.12998/wjcc.v10.i5.1457] [Reference Citation Analysis]
5 Feng S, Tong H, Gao JH, Tang SH, Yang WJ, Wang GM, Zhou HY, Wen SL. Anti-inflammation treatment for protection of hepatocytes and amelioration of hepatic fibrosis in rats. Exp Ther Med 2021;22:1213. [PMID: 34584558 DOI: 10.3892/etm.2021.10647] [Reference Citation Analysis]
6 Martens K, McMurry HS, Koprowski S, Hum J, Haraga J, Jou JH, Shatzel JJ. Anticoagulation in Cirrhosis: Evidence for the Treatment of Portal Vein Thrombosis and Applications for Prophylactic Therapy. J Clin Gastroenterol 2022. [PMID: 35537133 DOI: 10.1097/MCG.0000000000001713] [Reference Citation Analysis]
7 Tatsumi A, Maekawa S, Osawa L, Katoh R, Komiyama Y, Nakakuki N, Takada H, Matsuda S, Muraoka M, Suzuki Y, Sato M, Takahashi E, Miura M, Amemiya F, Takano S, Fukasawa M, Yamaguchi T, Nakayama Y, Inoue T, Okada H, Araki T, Onishi H, Enomoto N. Spontaneous portosystemic shunt diameter predicts liver function after balloon‐occluded retrograde transvenous obliteration. JGH Open. [DOI: 10.1002/jgh3.12712] [Reference Citation Analysis]
8 Hsu LI, Chen JW, Lin DT, Wei ST, Hou SM. The continued decline of plasma transfusions in Taiwan: An 11-year population-based study. Vox Sang 2021. [PMID: 34905221 DOI: 10.1111/vox.13222] [Reference Citation Analysis]
9 Ryu E, Xia HH, Guo GL, Zhang L. Multivariable-adjusted trends in mortality due to alcoholic liver disease among adults in the United States, from 1999-2017. Am J Transl Res 2022;14:1092-9. [PMID: 35273712] [Reference Citation Analysis]
10 Yoshiji H, Ueno Y, Kurosaki M, Torimura T, Hatano E, Yatsuhashi H, Yamakado K. Treatment algorithm for thrombocytopenia in patients with chronic liver disease undergoing planned invasive procedures. Hepatol Res 2021;51:1181-95. [PMID: 34555262 DOI: 10.1111/hepr.13715] [Reference Citation Analysis]
11 Kishimoto R, Suga M, Usumura M, Iijima H, Yoshida M, Hachiya H, Shiina T, Yamakawa M, Konno K, Obata T, Yamaguchi T. Shear wave speed measurement bias in a viscoelastic phantom across six ultrasound elastography systems: a comparative study with transient elastography and magnetic resonance elastography. J Med Ultrasonics. [DOI: 10.1007/s10396-022-01190-x] [Reference Citation Analysis]
12 Belcher JM, Parada XV, Simonetto DA, Juncos LA, Karakala N, Wadei HM, Sharma P, Regner KR, Nadim MK, Garcia-Tsao G, Velez JCQ, Parikh SM, Chung RT, Allegretti AS; HRS-HARMONY study investigators. Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward. Am J Kidney Dis 2021:S0272-6386(21)00890-8. [PMID: 34606933 DOI: 10.1053/j.ajkd.2021.08.016] [Reference Citation Analysis]